Cargando…

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19

Detalles Bibliográficos
Autores principales:	Kulkarni, Chanda, Sadiq, Adil, Gigi, Arya, Devassia, Ambili, George, Georgeena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641748/ https://www.ncbi.nlm.nih.gov/pubmed/34854415 http://dx.doi.org/10.4103/ijp.ijp_508_21

Ejemplares similares

COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right
por: Garg, Rakesh, et al.
Publicado: (2022)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
por: Kaminski, Hannah, et al.
Publicado: (2022)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

Dog bite, immunoglobulin, and preexposure vaccination
por: Pokee, Nora, et al.
Publicado: (2015)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Oral preexposure prophylaxis continuation, measurement and reporting
por: Stankevitz, Kayla, et al.
Publicado: (2020)

P41 - Preexposure prophylaxis of infants’ food allergy
por: Denisova, Svetlana, et al.
Publicado: (2014)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Evaluation of Trends in Preexposure Prophylaxis Prescriptions During the First 6 Months of the COVID-19 Pandemic in New York State
por: O’Grady, Thomas J., et al.
Publicado: (2022)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
por: Amico, K. Rivet, et al.
Publicado: (2014)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
por: Fonner, Virginia A., et al.
Publicado: (2016)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Preexposure Prophylaxis for the Prevention of HIV Infection — 2014 Available Online
Publicado: (2014)

Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States
por: Aaron, Erika, et al.
Publicado: (2018)

HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
por: Blaylock, Jason M., et al.
Publicado: (2018)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022)

Interest in Hypothetical Preexposure Prophylaxis Against Herpes Simplex Virus: A Cross-Sectional Survey
por: Tan, Darrell H. S., et al.
Publicado: (2021)

Addressing the Need for a Preexposure Prophylaxis Monitoring and Evaluation Implementation Guide: Experience From Zambia
por: Lavoie, Marie-Claude C., et al.
Publicado: (2023)

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
por: Nguyen, Vinh-Kim, et al.
Publicado: (2018)

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis
por: Fuchs, Jonathan D., et al.
Publicado: (2018)

HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
por: Huang, Ya-lin A., et al.
Publicado: (2018)

Preexposure prophylaxis strategies for African–American women affected by mass incarceration
por: Adams, Joëlla W., et al.
Publicado: (2021)

Women Trust Their OBGYNs to Provide Preexposure Prophylaxis: An Opportunity for HIV Prevention
por: Danvers, Antoinette A., et al.
Publicado: (2022)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Hydroxychloroquine: is there a role in long COVID?
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend
por: Hor, Chee Peng, et al.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2p933138oo7takjd4vt7vo6co2